Publication

Response to: "A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus"

Lambers, W. M., Westra, J., Bootsma, H. & de Leeuw, K., 25-Sep-2020, In : ARTHRITIS CARE & RESEARCH. 4 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Copy link to clipboard

Documents

  • Response to “A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus”

    Final author's version, 1.74 MB, PDF document

    Embargo ends: 25/09/2021

    Request copy

  • Response to “A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus”

    Final publisher's version, 1.74 MB, PDF document

    Request copy

DOI

We thank Dr Alexander and Dr Weinstein for their response to our review.1 We welcome the attempt to develop a diagnostic test that can predict progression to systemic lupus erythematosus (SLE). Early identification of SLE is one of the main challenges faced by clinicians, and is hindered by both the heterogeneous presenting symptoms of the disease, as well as overlap with other diseases.2,3 Timely treatment, however, is important in order to limit disease progression, and prevent organ damage and mortality.4.

Original languageEnglish
Number of pages4
JournalARTHRITIS CARE & RESEARCH
Publication statusE-pub ahead of print - 25-Sep-2020

ID: 136413333